Complete Response Following Treatment with Olaparib in a Patient with BRCA-Mutant High-Grade Serous Ovarian Cancer and Central Nervous System Metastases-Reference-Cited by-同舟云学术

Complete Response Following Treatment with Olaparib in a Patient with BRCA-Mutant High-Grade Serous Ovarian Cancer and Central Nervous System Metastases

Published:2023-04-15 Issue:2 Volume:21 Page:
ISSN:2363-8397
Container-title:Indian Journal of Gynecologic Oncology
language:en
Short-container-title:Indian J Gynecol Oncolog

Author:

AlSendi Maha^ORCID,Madan Ali,Malik Hanadi

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s40944-023-00710-y.pdf

Reference30 articles.

1. Jacobs IJ, Menon U, Ryan A, et al. Ovarian cancer screening and mortality in the UK collaborative trial of ovarian cancer screening (UKCTOCS): a randomised controlled trial. Lancet. 2016;387(10022):945–56. https://doi.org/10.1016/S0140-6736(15)01224-6.

2. Borella F, Bertero L, Morrone A, et al. Brain metastases from ovarian cancer: current evidence in diagnosis, treatment, and prognosis. Cancers (Basel). 2020;12(8):1–22. https://doi.org/10.3390/cancers12082156.

3. Sehouli J, Pietzner K, Harter P, et al. Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study. Ann Oncol. 2010;21(11):2201–5. https://doi.org/10.1093/annonc/mdq229.

4. Birkenhager TK. Both paroxetine and imipramine appear to be ineffective in adolescents with major depression, furthermore doubts have risen about their safety. Evid Based Med. 2016;21(3):92. https://doi.org/10.1136/ebmed-2015-110320.

5. Chiang YC, Qiu JT, Chang CL, et al. Brain metastases from epithelial ovarian carcinoma: evaluation of prognosis and managements - a Taiwanese GYNECOLOGIC oncology group (TGOG) study. Gynecol Oncol. 2012;125(1):37–41. https://doi.org/10.1016/j.ygyno.2011.12.438.